Impact of Multimodality Treatment Sequence on Survival in Stage IIB Non-Small Cell Lung Cancer

Submitted by: Christopher Anderson

Source: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2020.12.008

Keywords:

Author(s): Sean M. Stokes, MD, MS Nader N. Massarweh, MD, MPH John R. Stringham, MD Thomas K. Varghese Jr., MD, MS

The wroth of neoadjuvant treatment in conjunction with resection as multimodality therapy (MMT) for stage IIB non-small cell lung cancer is still controversial.

Add Comments

ADD TO PLAYLIST

Related Content